Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Hexetidine (NSC-17764): Advanced Strategies for Oral Infecti
2026-05-09
Explore the unique pharmacological and assay optimization insights for Hexetidine (NSC-17764), a leading antibacterial agent for oral infections. This article reveals practical guidance and scientific context not found in standard resources.
-
Indazole/Indole-Based Glucagon Receptor Antagonists: Synthes
2026-05-08
This study introduces a novel series of indazole- and indole-based glucagon receptor antagonists as potential therapeutics for type 2 diabetes. Through innovative synthetic strategies and structure–activity relationship (SAR) studies, several potent compounds with excellent in vitro and in vivo efficacy were identified, underscoring new directions for amide bond-driven drug design.
-
Gly-Gly-Phe-Gly (GGFG): Optimizing Bioconjugation Workflows
2026-05-08
Gly-Gly-Phe-Gly (GGFG) offers unmatched flexibility as a peptide linker, streamlining drug conjugation and antibody-drug conjugate (ADC) development. This article decodes practical workflows, troubleshooting strategies, and the translational impact of GGFG in advanced bioconjugation research.
-
p-tau Ser356 and NUAK1 Inhibition in Alzheimer’s Pathology
2026-05-07
This study identifies a strong association between tau phosphorylated at Ser356 (p-tau Ser356) and Alzheimer's disease (AD) progression, highlighting its accumulation in neurofibrillary tangles and synapses. NUAK1 inhibition via WZ4003 selectively reduces p-tau Ser356 in human brain slice cultures, suggesting site- and context-specific therapeutic potential.
-
HOBt (1-Hydroxybenzotriazole): Expanding Peptide Synthesis F
2026-05-07
Discover how HOBt (1-Hydroxybenzotriazole) drives next-generation peptide synthesis and amide bond formation. This in-depth analysis explores mechanistic innovations, recent research advances, and practical protocols that set new standards in minimizing epimerization and enabling complex molecule construction.
-
nor-Binaltorphimine Dihydrochloride in Opioid Receptor Assay
2026-05-06
nor-Binaltorphimine dihydrochloride is a selective κ-opioid receptor antagonist enabling unparalleled specificity in opioid receptor signaling research. This article details optimized protocols, troubleshooting strategies, and real-world applications that maximize reproducibility and insight for pain modulation and neurocircuitry studies.
-
Trichostatin A: Optimizing Epigenetic Regulation in Cancer M
2026-05-06
Trichostatin A (TSA) from APExBIO empowers researchers to finely modulate histone acetylation, enabling precise control of cell cycle arrest and differentiation in cancer and organoid models. This guide unpacks experimental workflows, troubleshooting, and recent innovations, helping scientists achieve reproducible, high-impact results in epigenetic regulation and cancer research.
-
Cell Integrity Sets Ploidy Limits in Budding Yeast: Mechanis
2026-05-05
This study uncovers how physical cell integrity constrains the maximum ploidy that Saccharomyces cerevisiae can tolerate, revealing links between increased DNA content, cell surface stress, and repression of membrane biosynthesis genes. These findings provide a framework for probing cell membrane integrity and ploidy interactions in fungal research.
-
Prolonging Corneal Epithelial Proliferation: A Novel 6C Cult
2026-05-05
An X et al. introduced a serum-free, small-molecule-based '6C medium' that preserves proliferative activity and epithelial identity in mouse corneal epithelial cells (mCEC). This innovation enables efficient expansion of mCEC for research and potential regenerative applications, notably by suppressing unwanted epithelial-mesenchymal transition.
-
Clathrin-Mediated Endocytosis in Grass Carp Reovirus Entry
2026-05-04
Wang et al. (2018) delineate the entry mechanism of genotype III grass carp reovirus (GCRV104), identifying clathrin-mediated, dynamin- and pH-dependent endocytosis as essential for infection. Their inhibitor-based analysis, including use of the PI3K inhibitor Wortmannin, highlights key host pathways involved and informs future antiviral strategy development.
-
Kinase Regulators of ECM Internalisation Drive Cancer Cell I
2026-05-04
The referenced study introduces a high-content screening approach to uncover novel kinase regulators of extracellular matrix (ECM) internalisation in invasive carcinoma cells. By identifying the α2β1 integrin/p38 MAPK signaling axis as a key modulator of ECM uptake and cell migration, the work advances mechanistic understanding relevant to cancer progression and metastasis.
-
APEX2 Is Essential for TERT Expression in Human Stem Cells
2026-05-03
This study uncovers an unexpected role for the DNA repair enzyme APEX2 in regulating TERT gene expression in human embryonic stem cells (hESCs) and melanoma cells. The findings link DNA damage repair at specific repetitive regions to control of telomerase activity, with implications for stem cell biology and cancer research.
-
XPO1 Inhibition Sensitizes GCB-DLBCL to Platinum Chemotherap
2026-05-02
This study demonstrates that inhibiting XPO1 using Selinexor enhances the efficacy of platinum-based chemotherapy in germinal-center B-cell-like diffuse large B-cell lymphoma (GCB-DLBCL) cell lines. The findings highlight synergistic mechanisms of apoptosis and ROS accumulation, supporting preclinical rationale for XPO1 inhibitor–platinum combinations in resistant lymphoma.
-
(+)-Bicuculline: Technical Use Guide and Workflow Parameters
2026-05-01
(+)-Bicuculline is a well-characterized GABAA receptor antagonist used to interrogate inhibitory neurotransmission and synaptic NMDA receptor signaling in neuroscience research. It is not suitable for diagnostic or clinical use. Reliable results require attention to solubility, storage, and experimental workflow as specified in product guidance.
-
Ornithine Cycle Disruption Drives CNS Toxicity in Realgar Ex
2026-05-01
This study uncovers how realgar-induced arsenic toxicity disrupts hepatic ornithine metabolism, leading to central nervous system (CNS) injury via ZBTB7A-mediated repression of astrocyte glycolysis. The findings establish a mechanistic link across the liver–brain axis, offering new molecular targets for mitigating CNS toxicity in arsenic exposures.